Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.1K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.1K
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.6K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.6K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.4K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.4K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

420
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
420
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

800
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
800

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Network Enhancement Method to Identify Spurious Drug-Drug Interactions.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same author

Pan-genomic analysis provides novel insights into the association of E.coli with human host and its minimal genome.

Bioinformatics (Oxford, England)·2018
Same author

Recombinational DSBs-intersected genes converge on specific disease- and adaptability-related pathways.

Bioinformatics (Oxford, England)·2018
Same author

[The protective effect of valproic acid on myocardium in rats with lethal scald injury and its mechanism].

Zhonghua wei zhong bing ji jiu yi xue·2014
Same author

Size evolution of ion beam synthesized Pb nanoparticles in Al.

Nanoscale research letters·2014
Same author

Sulfur copolymer nanowires with enhanced visible-light photoresponse.

Chemical communications (Cambridge, England)·2014
Same journal

circ2DGNN: circRNA-Disease Association Prediction via Transformer-Based Graph Neural Network.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

Hierarchical Hypergraph Learning in Association- Weighted Heterogeneous Network for miRNA- Disease Association Identification.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

Discriminative Domain Adaption Network for Simultaneously Removing Batch Effects and Annotating Cell Types in Single-Cell RNA-Seq.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

MLW-BFECF: A Multi-Weighted Dynamic Cascade Forest Based on Bilinear Feature Extraction for Predicting the Stage of Kidney Renal Clear Cell Carcinoma on Multi-Modal Gene Data.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

An End-to-End Knowledge Graph Fused Graph Neural Network for Accurate Protein-Protein Interactions Prediction.

IEEE/ACM transactions on computational biology and bioinformatics·2024
Same journal

Generative Biomedical Event Extraction With Constrained Decoding Strategy.

IEEE/ACM transactions on computational biology and bioinformatics·2024
查看所有相关文章

相关实验视频

Updated: Jul 26, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K

多种类型感知方法用于药物向相互作用预测.

Huan Wang, Ruigang Liu, Baijing Wang

    IEEE/ACM transactions on computational biology and bioinformatics
    |June 14, 2023
    PubMed
    概括
    此摘要是机器生成的。

    本研究引入了一种新的多种类型感知方法 (MPM),通过利用各种相互作用类型的多样化知识来预测药物向相互作用 (DTI). 通过学习每个交互的独特特征,MPM提高了准确性,超过了现有的最先进的方法.

    更多相关视频

    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
    06:50

    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

    Published on: January 26, 2024

    1.9K
    Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
    08:31

    Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

    Published on: December 1, 2020

    5.1K

    相关实验视频

    Last Updated: Jul 26, 2025

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    18.7K
    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
    06:50

    Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

    Published on: January 26, 2024

    1.9K
    Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
    08:31

    Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

    Published on: December 1, 2020

    5.1K

    科学领域:

    • 计算化学是一种计算化学.
    • 生物信息学是一种生物信息学.
    • 人工智能在药物发现中的作用

    背景情况:

    • 深度学习越来越多地用于预测药物向相互作用 (DTI).
    • 现有的方法往往无法整合来自各种相互作用类型 (例如药物-药物,药物-点,药物-酶) 的多样化知识.
    • 这种局限性阻碍了充分利用知识多样性来改进DTI预测.

    研究的目的:

    • 为DTI预测提出一种新的多种类型感知方法 (MPM).
    • 为了应对在不同类型的互动中利用知识多样性的挑战.
    • 提高DTI预测模型的准确性和稳定性.

    主要方法:

    • 开发了一种多种类型感知方法 (MPM),包括类型感知器和多种类型预测器.
    • 类型感知器学习区分边缘表示,保留每个交互类型的特定特征.
    • 多种类型预测器计算类型相似性,并使用域网模块进行自适应加权.

    主要成果:

    • MPM有效地利用跨不同链接类型的知识多样性进行DTI预测.
    • 类型感知器组件最大限度地提高了对个别交互类型的预测性能.
    • 广泛的实验证实了MPM的性能优于当前最先进的方法.

    结论:

    • 拟议的MPM通过整合多样化的交互知识,在DTI预测方面取得了重大进展.
    • 这种方法提高了深度学习模型在药物发现中的预测能力.
    • MPM提供了一种更全面的策略,用于理解和预测药物向关系.